Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
American Journal of Human Genetics|March 1, 1992
Strong allelic association between the torsion dystonia gene (DYT1) andloci on chromosome 9q34 in Ashkenazi JewsL J Ozelius, P L Kramer, D de Leon, et al.Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaM F Brin, M F Lew, C H Adler, et al.Neurology|February 1, 1994
A study of idiopathic torsion dystonia in a non-Jewish family: evidence for genetic heterogeneityS B Bressman, G A Heiman, T G Nygaard, et al.Neurology|October 23, 2002
Clinical findings of a myoclonus-dystonia family with two distinct mutationsD Doheny, F Danisi, C Smith, et al.Human Molecular Genetics|June 9, 1998
De novo mutations (GAG deletion) in the DYT1 gene in two non-Jewish patients with early-onset dystoniaC Klein, M F Brin, D de Leon, et al.Genomics|January 25, 2000
The TOR1A (DYT1) gene family and its role in early onset torsion dystoniaL J Ozelius, C E Page, C Klein, et al.Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystoniaA Brashear, M F Lew, D D Dykstra, et al.Genetic Testing|January 11, 2000
Genetic testing for early-onset torsion dystonia (DYT1): introduction of a simple screening method, experiences from testing of a large patient cohort, and ethical aspectsC Klein, J Friedman, S Bressman, et al.Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.Neurology|June 13, 2001
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremorM F Brin, K E Lyons, J Doucette, et al.Pageof 11